Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Galera Therapeutics ( (GRTX) ) has provided an announcement.
On April 7, 2026, Galera Therapeutics, Inc. converted 76,479.175 shares of its Series B Non-Voting Convertible Preferred Stock into 76,479,164 shares of common stock, paying cash in lieu of fractional shares and leaving 42,839.11 Series B Preferred shares outstanding after the transaction. On April 8, 2026, affiliates of Ikarian Capital, LLC partially exercised pre-funded warrants to acquire 8,488,229 common shares at a nominal exercise price, providing the company with approximately $8,488 in proceeds and leaving pre-funded warrants for an additional 14,552,811 common shares outstanding, which increases Galera’s outstanding share count and maintains potential future dilution overhang for existing shareholders.
The most recent analyst rating on (GRTX) stock is a Hold with a $0.05 price target. To see the full list of analyst forecasts on Galera Therapeutics stock, see the GRTX Stock Forecast page.
Spark’s Take on GRTX Stock
According to Spark, TipRanks’ AI Analyst, GRTX is a Neutral.
The score is held back primarily by weak financial performance (no revenue, ongoing operating losses, and limited evidence of sustainable cash generation), despite improved balance-sheet positioning in 2025. Technicals are relatively supportive with an uptrend and positive MACD, while valuation signals are unreliable due to likely non-operating earnings. The corporate event modestly helps by improving capital-structure flexibility but carries dilution risk.
To see Spark’s full report on GRTX stock, click here.
More about Galera Therapeutics
Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics, with its capital structure comprising common stock and preferred stock, including Series B Non-Voting Convertible Preferred Stock, as well as pre-funded warrants held by institutional investors. The company actively manages its equity and warrant instruments, which influence its share count and investor base.
Average Trading Volume: 58,521
Technical Sentiment Signal: Hold
Current Market Cap: $3.11M
Find detailed analytics on GRTX stock on TipRanks’ Stock Analysis page.